Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATFurniture, Fixtures and OtherLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

CytomX Therapeutics (CTMX) Other Gross PP&E Adjustments (2016 - 2025)

CytomX Therapeutics' Other Gross PP&E Adjustments history spans 12 years, with the latest figure at $384000.0 for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments rose 109.69% year-over-year to $384000.0; the TTM value through Dec 2025 reached $384000.0, up 109.69%, while the annual FY2025 figure was $384000.0, 109.69% up from the prior year.
  • Other Gross PP&E Adjustments reached $384000.0 in Q4 2025 per CTMX's latest filing, up from -$5.5 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $384000.0 in Q4 2025 to a low of -$23.0 million in Q2 2021.
  • Average Other Gross PP&E Adjustments over 5 years is -$13.0 million, with a median of -$12.4 million recorded in 2024.
  • Peak YoY movement for Other Gross PP&E Adjustments: crashed 52.36% in 2022, then skyrocketed 109.69% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at -$7.4 million in 2021, then plummeted by 52.36% to -$11.2 million in 2022, then grew by 28.1% to -$8.1 million in 2023, then skyrocketed by 50.84% to -$4.0 million in 2024, then surged by 109.69% to $384000.0 in 2025.
  • Per Business Quant, the three most recent readings for CTMX's Other Gross PP&E Adjustments are $384000.0 (Q4 2025), -$5.5 million (Q3 2025), and -$7.3 million (Q2 2025).